Literature DB >> 31451008

Case of Noonan Syndrome With an Expanding Coronary Arterial Aneurysm.

Yoshito Ogihara1, Naoki Fujimoto1, Hiroyuki Ohashi2, Naoki Yamamoto3, Hisato Ito3, Yoshihide Mitani2, Yoko Aoki4, Kyoko Imanaka-Yosida5, Masaaki Ito1, Kaoru Dohi1.   

Abstract

Entities:  

Keywords:  Noonan syndrome; aneurysm; cardiovascular diseases; pathology; tomography

Year:  2019        PMID： 31451008      PMCID： PMC7099851          DOI： 10.1161/CIRCIMAGING.119.009429

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN： 1941-9651            Impact factor:   7.792


× No keyword cloud information.
  4 in total

1.  Development of bilateral coronary artery aneurysms in a child with Noonan syndrome.

Authors:  David M Mauro; Lucia Flors; Andrew W Hoyer; Patrick T Norton; Klaus D Hagspiel
Journal:  Pediatr Radiol       Date:  2015-10-29

2.  Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: a Ras/MAPK pathway syndrome.

Authors:  Angela E Lin; Mark E Alexander; Steven D Colan; Bronwyn Kerr; Katherine A Rauen; Jacqueline Noonan; Jeanne Baffa; Elizabeth Hopkins; Katia Sol-Church; Giuseppe Limongelli; Maria Christina Digilio; Bruno Marino; A Micheil Innes; Yoko Aoki; Michael Silberbach; Marie-Ange Delrue; Susan M White; Robert M Hamilton; William O'Connor; Paul D Grossfeld; Leslie B Smoot; Robert F Padera; Karen W Gripp
Journal:  Am J Med Genet A       Date:  2011-02-22       Impact factor: 2.802

3.  Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.

Authors:  M Tartaglia; E L Mehler; R Goldberg; G Zampino; H G Brunner; H Kremer; I van der Burgt; A H Crosby; A Ion; S Jeffery; K Kalidas; M A Patton; R S Kucherlapati; B D Gelb
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

Review 4.  Noonan syndrome and clinically related disorders.

Authors:  Marco Tartaglia; Bruce D Gelb; Martin Zenker
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-02       Impact factor: 4.690
  4 in total
  1 in total

1.  MEK Inhibition in a Newborn with RAF1-Associated Noonan Syndrome Ameliorates Hypertrophic Cardiomyopathy but Is Insufficient to Revert Pulmonary Vascular Disease.

Authors:  Alessandro Mussa; Diana Carli; Elisa Giorgio; Anna Maria Villar; Simona Cardaropoli; Caterina Carbonara; Maria Francesca Campagnoli; Paolo Galletto; Martina Palumbo; Simone Olivieri; Claudio Isella; Gregor Andelfinger; Marco Tartaglia; Giovanni Botta; Alfredo Brusco; Enzo Medico; Giovanni Battista Ferrero
Journal:  Genes (Basel)       Date:  2021-12-21       Impact factor: 4.096
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.